Page last updated: 2024-08-24

sertraline and Vascular Diseases

sertraline has been researched along with Vascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barch, DM; Doraiswamy, PM; DʼAngelo, G; Garcia, KS; Gersing, K; Pieper, C; Sheline, YI; Taylor, W; Welsh-Bohmer, K; Wilkins, CH1
Clary, CM; Doraiswamy, PM; Krishnan, KR1

Trials

2 trial(s) available for sertraline and Vascular Diseases

ArticleYear
Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2012, Volume: 20, Issue:8

    Topics: Age of Onset; Aged; Antidepressive Agents; Cognition Disorders; Depression; Executive Function; Female; Humans; Male; Memory; Mental Status Schedule; Sertraline; Severity of Illness Index; Treatment Outcome; Vascular Diseases

2012
Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline.
    Progress in neuro-psychopharmacology & biological psychiatry, 2001, Volume: 25, Issue:2

    Topics: Age of Onset; Aged; Antidepressive Agents; Anxiety; Cardiovascular Diseases; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Hypertension; Male; Mental Status Schedule; Middle Aged; Nortriptyline; Patient Selection; Placebos; Psychiatric Status Rating Scales; Safety; Sertraline; Vascular Diseases

2001